We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




First Lung Cancer Patients Treated Using MRI-Guided Radiotherapy

By HospiMedica International staff writers
Posted on 19 Feb 2014
One of the first treatments of stereotactic body radiation therapy (SBRT) for lung cancer patients is being used with a new magnetic resonance imaging (MRI)-guided radiotherapy system.

MRI-guided radiation therapy enables clinicians to see a patient’s internal anatomy in real-time and keep the radiation beams on the target when the tumor moves during treatment. More...
SBRT is a type of radiation therapy in which a few very high doses of radiation are delivered to small, well-defined tumors to kill cancer cells while minimizing exposure to neighboring healthy organs.

The ViewRay (Cleveland, OH, USA) system, the world’s first MRI-guided radiation therapy system, is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis (MO, USA). The ViewRay system provides a patented combination of simultaneous radiation therapy delivery and continuous MRI scanning for the treatment of cancer.

“Treating patients is a key milestone for ViewRay, but more importantly, it marks a significant advance in cancer care,” said Chris A. Raanes, ViewRay president and CEO. “MRI-guided radiation therapy is no longer a research quest; today, it has become real and offers physicians a new and powerful weapon for treating cancer.”

An international institution focused on cancer treatment and research, the Siteman Cancer Center has a long history of adopting and helping to develop new technology with a focus on improving patient care and outcomes. “Real-time MR guidance offers a way to treat tumors that move with respiration,” said Jeffrey Bradley, MD, a professor of radiation oncology at Siteman Cancer Center and Washington University School of Medicine. “Our physicians and physicists report the ability to see tumors move in real-time during the entire treatment. This helps to ensure that tumor targets are hit and healthy tissue is spared.”

ViewRay is a medical device company that develops sophisticated radiation therapy technology for the treatment of cancer. The ViewRay system provides continuous soft-tissue imaging during radiation therapy using MRI-guidance, so that clinicians are able to see exactly where the radiation dose is being delivered and adapt to changes in the patient’s anatomy.

The Siteman Cancer Center is the only US National Cancer Institute designated Comprehensive Cancer Center in the state Missouri.

Related Links:

ViewRay
Washington University School of Medicine in St. Louis



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Infant Incubator
OKM 801
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.